CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 102 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,003 | -99.7% | 160,000 | +60.0% | 1.20% | +206.4% |
| Q3 2022 | $350,000 | -43.5% | 100,000 | -52.4% | 0.39% | -40.8% |
| Q2 2022 | $620,000 | +32.8% | 210,000 | +40.0% | 0.66% | +68.4% |
| Q1 2022 | $467,000 | -7.9% | 150,000 | 0.0% | 0.39% | +2.3% |
| Q4 2021 | $507,000 | -7.5% | 150,000 | 0.0% | 0.38% | -6.4% |
| Q3 2021 | $548,000 | -16.2% | 150,000 | 0.0% | 0.41% | -13.5% |
| Q2 2021 | $654,000 | -4.0% | 150,000 | 0.0% | 0.47% | -6.5% |
| Q1 2021 | $681,000 | – | 150,000 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
| Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
| Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
| Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
| Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
| Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
| Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
| MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |